Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Profit After Tax: 2009-2021

Historic Profit After Tax for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -$85.5 million.

  • Avadel Pharmaceuticals' Profit After Tax fell 105.14% to -$23.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$88.2 million, marking a year-over-year decrease of 157.73%. This contributed to the annual value of -$85.5 million for FY2021, which is 1317.22% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Profit After Tax of -$85.5 million as of FY2021, which was down 1,317.22% from $7.0 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Profit After Tax ranged from a high of $68.3 million in FY2017 and a low of -$95.3 million during FY2018.
  • Moreover, its 3-year median value for Profit After Tax was -$33.2 million (2019), whereas its average is -$37.2 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Profit After Tax surged by 265.40% in 2017, and later plummeted by 1,317.22% in 2021.
  • Avadel Pharmaceuticals' Profit After Tax (Yearly) stood at $68.3 million in 2017, then crashed by 239.60% to -$95.3 million in 2018, then skyrocketed by 65.14% to -$33.2 million in 2019, then skyrocketed by 121.15% to $7.0 million in 2020, then crashed by 1,317.22% to -$85.5 million in 2021.